Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-10-000067
Filing Date
2010-11-12
Accepted
2010-11-10 18:03:18
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-093010.htm 10-Q 721541
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 17921
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 17938
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6195
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6205
  Complete submission text file 0000318306-10-000067.txt   771420
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 101181284
SIC: 2834 Pharmaceutical Preparations